Periconceptional use of opioids and the risk of neural tube defects

Obstetrics and Gynecology

Volumn 122, Issue 4, 2013, Pages 838-844

  Yazdy, Mahsa M ^a,b   Mitchell, Allen A ^a,b   Tinker, Sarah C ^a,b   Parker, Samantha E ^a,b   Werler, Martha M ^a,b  

^a BOSTON UNIVERSITY   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE DERIVATIVE;

ADULT; ARTICLE; DELIVERY; DRUG INDICATION; FEMALE; HEADACHE; HUMAN; INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MOTHER; NEURAL TUBE DEFECT; OPIATE ADDICTION; PAIN; PREGNANCY; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PROGENY; RISK ASSESSMENT; SPINAL DYSRAPHISM;

ADULT; ANALGESICS, OPIOID; CASE-CONTROL STUDIES; FEMALE; FERTILIZATION; FETAL DEVELOPMENT; HUMANS; LOGISTIC MODELS; NEURAL TUBE DEFECTS; PREGNANCY; YOUNG ADULT;

EID: 84889773066     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3182a6643c     Document Type: Article

References (33)

1. Kuehn BM. Opioid prescriptions soar. JAMA 2007;297:249-51.
2. Manchikanti L. National drug control policy and prescription drug abuse: facts and fallacies. Pain Physician 2007;10:399-424.
3. Manchikanti L, Singh A. Therapeutic opioids: A ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008; 11(suppl):S63-88.
4. Kelley K, Kelley T, Kaufman D, Mitchell A. The Slone Drug Dictionary: A research driven pharmacoepidemiology tool. Pharmacoepidemiol Drug Saf 2003;12(suppl 1):S168-9.
5. Munoz MA, Stojanovic D, Etminan M, Winterstein AG, Delaney J. Trends in use of benzodiazepines, opioids, tramadol, and Z-drugs from 1998 to 2008 in a managed care population. Pharmacoepidemiol Drug Saf 2012;21(suppl 3):426.
6. Campbell CI, Weisner C, LeResche L, Ray GT, Saunders K, Sullivan MD, et al. Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health 2010;100: 2541-7.
7. Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, Riehle-Colarusso T, et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 2011;204:314.e1-11.
8. Epstein RA, Ray WA, Bobo WV, Martin PR, Morrow JA, Arbogast PG, et al. Increasing first trimester use of opioid analgesics. Pharmacoepidemiol Drug Saf 2012;21(suppl 3):370.
9. Villee CA. Placental transfer of drugs. Ann N Y Acad Sci 1965; 123:237-44.
10. de Castro A, Jones HE, Johnson RE, Gray TR, Shakleya DM, Huestis MA. Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes. Ther Drug Monit 2011; 33:443-52.
11. Kokki M, Franco MG, Raatikainen K, Välitalo P, Sankilampi U, Heinonen S, et al. Intravenous oxycodone for pain relief in the first stage of labour-maternal pharmacokinetics and neonatal exposure. Basic Clin Pharmacol Toxicol 2012;111:182-8.
12. Geber W, Schramm L. Congenital malformations of the central nervous system produced by narcotic analgesics in the hamster. Am J Obstet Gynecol 1975;123:705-13.
13. Jurand A. Teratogenic activity of methadone hydrochloride in mouse and chick embryos. J Embryol Exp Morphol 1973;30: 449-58.
14. Jurand A. Malformations of the central nervous system induced by neurotropic drugs in mouse embryos. Dev Growth Differ 1980;22:61-78.
15. Nasiraei-Moghadam S, Sahraei H, Bahadoran H, Sadooghi M, Salimi SH, Kaka GR, et al. Effects of maternal oral morphine consumption on neural tube development in Wistar rats. Brain Res Dev Brain Res 2005;159:12-7.
16. Bracken MB, Holford TR. Exposure to prescribed drugs in pregnancy and association with congenital malformations. Obstet Gynecol 1981;58:336-44.
17. Heinonen OP, Slone D, Shapiro S. Analgesics and antipyretic drugs. Birth defects and drugs in pregnancy. Littleton (MA): Publishing Sciences Group Inc; 1977. p. 286-95.
18. Louik C, Lin AE, Werler MM, Hernández-Díaz S, Mitchell AA. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 2007;356:2675-83.
19. Werler MM, Hayes C, Louik C, Shapiro S, Mitchell AA. Multivitamin supplementation and risk of birth defects. Am J Epidemiol 1999;150:675-82.
20. Mitchell AA, Rosenberg L, Shapiro S, Slone D. Birth defects related to bendectin use in pregnancy. I. Oral clefts and cardiac defects. JAMA 1981;245:2311-4.
21. Werler MM. Birth defects. In: Buck Louis GM, Platt RW, editors. Reproductive and perinatal epidemiology. Oxford University Press; 2011. p. 186-203.
22. Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, et al. Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 2010;88:1008-16.
23. Shaw GM, Todoroff K, Velie EM, Lammer EJ. Maternal illness, including fever, and medication use as risk factors for neural tube defects. Teratology 1998;57:1-7.
24. Kirby ML. Reduction of fetal rat spinal cord volume following maternal morphine injection. Brain Res 1980;202:143-50.
25. Zagon I, McLaughlin PJ. Neuronal cell deficits following maternal exposure to methadone in rats. Cell Mol Life Sci 1982;38: 1214-6.
26. Peters MA. The effect of maternally administered methadone on brain development in the offspring. J Pharmacol Exp Ther 1977;203:340-6.
27. Peters MA. Development of a 'blood-brain barrier' to methadone in the newborn rat. J Pharmacol Exp Ther 1975;192:513-20.
28. Shah NS, May DA, Yates JD. Disposition of levo-[3H]Cocaine in pregnant and nonpregnant mice. Toxicol Appl Pharmacol 1980;53:279-84.
29. Dow-Edwards D. Fetal and maternal cocaine levels peak rapidly following intragastric administration in the rat. J Subst Abuse 1990;2:427-37.
30. Waddell WJ. Localization and metabolism of drugs in the fetus. Fed Proc 1972;31:52-61.
31. Zagon IS, MacLaughlin PJ. Endogenous opioid systems regulate cell proliferation in the developing rat brain. Brain Res 1987;412:68-72.
32. Zagon IS, Wu Y, McLaughlin PJ. Opioid growth factor and organ development in rat and human embryos. Brain Res 1999;839:313-22.
33. Darmani NA, Schnoll SH, Pandey U, Martin BR. Chronic prenatal methadone exposure alters central opioid m-receptor affinity in both fetal and maternal brain. Neurotoxicol Teratol 1992; 14:265-71.